Trending Stock News

As Applied Materials (AMAT) Valuation Rose, Trust Co Of Vermont Has Trimmed Position; Garrison Financial Stake in Abbvie (ABBV) Has Decreased by $542,688

AbbVie Inc. (NYSE:ABBV) Logo

Trust Co Of Vermont decreased its stake in Applied Materials Inc (AMAT) by 10.81% based on its latest 2017Q4 regulatory filing with the SEC. Trust Co Of Vermont sold 6,391 shares as the company’s stock rose 6.49% while stock markets declined. The institutional investor held 52,755 shares of the technology company at the end of 2017Q4, valued at $2.70M, down from 59,146 at the end of the previous reported quarter. Trust Co Of Vermont who had been investing in Applied Materials Inc for a number of months, seems to be less bullish one the $52.89B market cap company. The stock increased 0.58% or $0.29 during the last trading session, reaching $50.34. About 12.81M shares traded. Applied Materials, Inc. (NASDAQ:AMAT) has risen 42.67% since May 24, 2017 and is uptrending. It has outperformed by 31.12% the S&P500.

Garrison Financial Corp decreased its stake in Abbvie Inc. (ABBV) by 7.89% based on its latest 2017Q4 regulatory filing with the SEC. Garrison Financial Corp sold 5,653 shares as the company’s stock declined 6.31% with the market. The institutional investor held 66,000 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $6.38 million, down from 71,653 at the end of the previous reported quarter. Garrison Financial Corp who had been investing in Abbvie Inc. for a number of months, seems to be less bullish one the $167.58 billion market cap company. The stock decreased 0.59% or $0.63 during the last trading session, reaching $105.6. About 12.82M shares traded or 75.69% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since May 24, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. It worsened, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Huber Mngmt Ltd Llc holds 0.08% or 15,237 shares in its portfolio. Kidder Stephen W, Massachusetts-based fund reported 36,888 shares. Sageworth Trust Communication invested in 111,410 shares. Lpl Ltd reported 604,066 shares stake. Kentucky Retirement Ins Fund invested in 42,334 shares or 0.68% of the stock. Bruce And stated it has 4.88% in AbbVie Inc. (NYSE:ABBV). Dearborn Ptnrs Limited Co reported 0.12% stake. 17,730 were accumulated by Baldwin Mgmt Limited. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management accumulated 0.01% or 10,300 shares. Sumitomo Mitsui Trust reported 0.58% of its portfolio in AbbVie Inc. (NYSE:ABBV). Rothschild Inv Il holds 1.85% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 176,186 shares. 35,024 are held by Lmr Partners Ltd Liability Partnership. Cornerstone invested in 1.29% or 117,000 shares. Dumont Blake Ltd Liability Company has invested 0.91% in AbbVie Inc. (NYSE:ABBV). Deutsche Comml Bank Ag stated it has 4.16 million shares.

Garrison Financial Corp, which manages about $191.27 million US Long portfolio, upped its stake in Schwab Us Broad Mkt (SCHB) by 5,055 shares to 26,684 shares, valued at $1.72M in 2017Q4, according to the filing.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 EPS, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $3.13 billion for 13.40 P/E if the $1.97 EPS becomes a reality. After $1.87 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

Since December 14, 2017, it had 0 insider buys, and 11 selling transactions for $47.70 million activity. Another trade for 25,000 shares valued at $2.95M was sold by Schumacher Laura J. CHASE WILLIAM J also sold $8.31 million worth of AbbVie Inc. (NYSE:ABBV) shares. 4,294 shares valued at $512,853 were sold by Michael Robert A. on Wednesday, February 28. 1,337 AbbVie Inc. (NYSE:ABBV) shares with value of $157,458 were sold by SALEKI-GERHARDT AZITA. SEVERINO MICHAEL sold $311,684 worth of stock or 2,643 shares. On Wednesday, February 28 the insider GONZALEZ RICHARD A sold $976,084.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: 247Wallst.com which released: “Why One Old Stock Buyback Trick Is Working So Well for AbbVie” on May 01, 2018, also Seekingalpha.com with their article: “AbbVie Is Still A One-Trick Pony” published on April 26, 2018, Fool.com published: “Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)” on May 02, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie: Protection Kicks In” published on April 25, 2018 as well as Streetinsider.com‘s news article titled: “Abbvie (ABBV) PT Lowered to $78 at BMO Capital” with publication date: May 23, 2018.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 92 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by SunTrust given on Wednesday, July 22. The company was downgraded on Monday, January 29 by Leerink Swann. On Thursday, March 22 the stock rating was maintained by SunTrust with “Buy”. The firm earned “Buy” rating on Friday, October 23 by UBS. The firm has “Overweight” rating given on Monday, November 2 by Morgan Stanley. The firm has “Hold” rating by BMO Capital Markets given on Friday, April 28. BMO Capital Markets maintained AbbVie Inc. (NYSE:ABBV) on Wednesday, May 23 with “Underperform” rating. Morgan Stanley downgraded AbbVie Inc. (NYSE:ABBV) rating on Wednesday, June 8. Morgan Stanley has “Equal-Weight” rating and $65 target. As per Friday, February 5, the company rating was initiated by William Blair. The stock has “Outperform” rating by Cowen & Co on Wednesday, October 11.

Trust Co Of Vermont, which manages about $1.08 billion US Long portfolio, upped its stake in Vanguard Short Term Inflation Prot Secs Etf (VTIP) by 8,645 shares to 162,471 shares, valued at $7.93 million in 2017Q4, according to the filing. It also increased its holding in I Shares Core S&P Mid (IJH) by 1,633 shares in the quarter, for a total of 117,093 shares, and has risen its stake in 3M (NYSE:MMM).

More notable recent Applied Materials, Inc. (NASDAQ:AMAT) news were published by: Seekingalpha.com which released: “Tracking David Tepper’s Appaloosa Management Portfolio – Q1 2018 Update” on May 21, 2018, also Nasdaq.com with their article: “Applied Materials Delivers Strong Year-On-Year Growth in Quarterly Revenue and Earnings Per Share” published on May 17, 2018, Nasdaq.com published: “Investor Fears in Applied Materials, Inc. Are Overblown — Profit From Them” on May 18, 2018. More interesting news about Applied Materials, Inc. (NASDAQ:AMAT) were released by: Nasdaq.com and their article: “Applied Materials, Inc. Stock Was Hammered by Earnings, Time to Profit” published on May 21, 2018 as well as Streetinsider.com‘s news article titled: “UPDATE: Applied Materials (AMAT) Added to Citi Focus List” with publication date: May 24, 2018.

Since December 29, 2017, it had 0 buys, and 4 insider sales for $10.41 million activity. Forrest Stephen R sold $214,680 worth of stock. On Thursday, March 8 Iannotti Thomas J sold $922,050 worth of Applied Materials, Inc. (NASDAQ:AMAT) or 15,000 shares. 53,466 shares valued at $2.83 million were sold by Nalamasu Omkaram on Tuesday, January 2.

Applied Materials, Inc. (NASDAQ:AMAT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *